Col4a1+/SVC display increased levels of Iba1, a marker for neuroglial activation that is the initial step in the central nervous system inflammatory response following stroke (35), which was reduced in treated mice (Fig. 1F and G), supporting reduced cerebrovascular disease severity and neuroinflammation. The gene discussed is COL4A1; the disease is cerebrovascular disorder.